8037 (8037) Fair Value & Analysis
Healthcare · Market cap HK$417M
Fair value as of: Jul 2, 2026
From 1 valuation models · updated today
Share price −24.6% over the past month.
Price vs Fair Value (12 months)
12‑month range HK$0.4300 – HK$1.22 · fair‑value band HK$0.1000 – HK$0.2000 · the HK$0.4300 price screens above the HK$0.1300 fair value. As of Jul 2, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
8037 (8037) currently trades at HK$0.4300, while our model-based Fair Value estimate is HK$0.1300 — implying the stock looks roughly 69.8% overvalued today. We read business quality at 34/100 (below-average quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).
Over the trailing twelve months, 8037 generated revenue of HK$73.5M at a net margin of -93.6%. Revenue declined 9.0% year over year. It earns a return on equity of -40.6%. Net debt stands at HK$383M. Fundamentals as of Jul 2, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 2, 2026. TTM = trailing twelve months.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
8037 reported revenue of HK$73.5M in FY2025 versus HK$624M in FY2021, a compound −41.4%/yr. Reported net income was −HK$68.8M in FY2025.
Is 8037 fairly valued? → Check now
Similar stocks
6 more Diagnostics & Research stocks, each showing price versus our Fair Value estimate (as of Jul 2, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Thermo Fisher Scientific Inc TMO | $472.80 | $190.31 | -60% |
| Danaher Corporation DHR | $186.64 | $85.95 | -54% |
| 2359 2359 | HK$152.80 | HK$120.99 | -21% |
| WuXi AppTec Co WUXAY | $18.59 | $25.09 | +35% |
| IDEXX Laboratories, Inc IDXX | $545.73 | $255.77 | -53% |
| Lonza Group LZAGY | $63.74 | $25.98 | -59% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is 8037 (8037) undervalued?
What is the fair value of 8037?
What is the quality score of 8037?
What is the revenue of 8037 (8037)?
What is the net profit margin of 8037?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.